(548 Results)
Filter
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Can we break the cycle of lung function decline and asthma exacerbations driven by type 2 inflammation in asthma?Guy Brusselle, Klaus F. Rabe This Company Sponsored Symposia ha...
-
To eat or not to eat: that is the questionNutrition and gut health for prevention of food allergy ...
-
IgE-mediated food allergy: need for a revolutionPanel discussion: Why do we need to be concerned about food allergy? What is the role of I...
-
The complex world of allergy. Patient’s needs in real lifeThe complex world of allergy. Patient’s needs in real life ...
-
Peanut allergy and investigational DBV712: an updateIntroduction Antonella Muraro ...
-
Breaking new ground: A closer look at Type 2 Inflammation in pediatric asthma
-
Type 2 Inflammation: What every clinician should knowHans In‘t Veen, Jasper Kappen This Company Sponsored Symposia...
-
Reconsider the art of AITWelcome and introduction Pati...
-
Pediatric Severe Asthma: Why Lung Function Matters
-
Childhood Asthma and the Impact of Type 2 InflammationOpening Remarks The Burden of...
-
Meet the experts on AIT in Food AllergyWelcome & Introduction Hans Van Schij...
-
Asthma, does allergy matter?Welcome and introduction/1 Pablo Rodrígue...
-
Re-thinking lung function testing in young children
-
A transformational approach to managing allergies to catsIntroduction Antonella Muraro ...
-
Clinical Cases in discussion: 3 patients, 3 experts & 1 solutionPablo Rodríguez Del Río, Torsten Zuberbier, Fulvio Braido, Mélisande Rouger
-
Furthering AIT`s promises with precision medicineOpening remarks G.Walter Canonica ...
-
Navigating Type 2 Inflammation across the skin, airway, and esophagusNavigating Type 2 Inflammation across the skin, airway, and esophagus ...
-
Improving patients’ journeys in food allergyWelcome and introduction Alexandra Santos ...
-
Exploring the Role of Type 2 Inflammation in Dermatologic DiseasesAtopic Dermatitis and the Type 2 Inflammatory Disease Spectrum ...
-
A novel dual key solution to unlock the treatment of allergic rhinitisClinical challenges and management strategies in allergic rhinitis: where are we? ...
-
Championing change: Is elimination of oral corticosteroid use in asthma achievable today?
-
IgE in asthma and nasal polyposis: your questions answered
-
Severe type 2 asthma: phenotypes and precision treatment for patientsOpening remarks Stephanie Korn, Enrico Hef...
-
Mometasone furoate/ olopatadine: the value of novelty patient-centred careIntroduction and Patient Testimony ...
-
Ameliorating atopy by targeted micronutrient supplementation with beta-lactoglobulinFranziska Roth-Walter
-
Managing severe asthma and CRSwNP: Through the lens of Type 2 InflammationOpening remarks Santiago Quirce ...
-
Targeting Type 2 mechanisms in patients with atopic dermatitis and comorbid Type 2 Inflammatory disease: A case-based reflectionConnecting Type 2 Inflammation to clinical characteristics of disease
-
Allergic patient: The Real WorldIntroduction European patient...
-
Exploring the Complexity of Chronic Spontaneous UrticariaChronic Spontaneous Urticaria (CSU): unpredictable, chronic and burdensome ...
-
How can we improve the approach to treating chronic urticaria in children?Introduction Montserrat Alvaro Lozano ...
-
Changing the way babies eat: Supporting early allergen feeding around the worldIntroduction Angela Claver Monzón ...
-
Expansion of Hydrolysed Rice Formula for Infants with Cow’s Milk Allergy: Considerations for Clinical PracticeExpansion of Hydrolysed Rice Formula for Infants with Cow’s Milk Allergy: Considerations...
-
A New Age in the Management of Pediatric Atopic Dermatitis: Evolution of Disease Understanding and Treatment OpportunitiesComorbidities in Children and Adolescents with Atopic Dermatitis ...
-
Systemic Mastocytosis – An Allergist/Immunologist PerspectiveVito Sabato
-
How do HMO modulate the immune system in infants with CMPA? emerging evidence and clinical implications.Introduction Clinical implica...
-
Rethinking hereditary angioedema: What role can the first oral plasma kallikrein inhibitor play?Reflection on hereditary angioedema (HAE): Progress and perspectives ...
-
Allergen composition of preparations translate into clinical outcomes of AITWelcome and introduction Suzanne Lau ...
-
Complete control of chronic spontaneous urticaria – mission (im)possible?
-
Patients with peanut allergy: the hope for a better life?Introduction Antonella Muraro ...
-
Advances in eosinophilic diseases
-
Yesterday’s vision is today’s opportunity to address Type 2 Inflammation in pediatric and adult atopic dermatitis patientsIntroduction Tilo Biedermann ...
-
Autoimmunity and immune deficits in IEI – uncovering APDSWelcome and Introduction Diag...
-
A unified approach: Improving patient outcomes in severe asthma and comorbid eosinophilic diseasesWelcome and introduction Peter Howarth, G....
-
Filling the gaps in asthma careTraining the immune system with microbial products ...
-
SCIT; pioneering a new eraIntroduction Venom Immunothe...
-
Everything you always wanted to know about SCIT but were afraid to askSCIT: Long-term efficacy Andrzej Bozek ...
-
Efficacy and quality of life in HAE: The lanadelumab experience
-
Focus on TAKHZYRO and real-world evidence: Why it matters for your patients with hereditary angioedema (HAE)Welcome and introduction Milos Jesenak ...
-
The Link between Early Diet and Food AllergyIntroduction Liam O’Mahony ...
-
MicroCrystalline Tyrosine-associated allergoids: Reaching the top of the evidence pyramidRalph Mösges
-
Hereditary angioedema (HAE): no patients left behindWelcome and introduction HAE ...
-
The Evolving Evidence for the Long-Term, Prophylactic Treatment of Hereditary Angioedema Patients with Subcutaneous C1-INHWelcome and Introduction Marcus Maurer ...
-
Relegating OCS to last resort: Creating a paradigm shift in asthma managementAstraZeneca: Relegating OCS to last resort: Creating a paradigm shift in asthma management...
-
Targeted therapy for patients with severe eosinophilic asthma – an interactive conversation with experts
-
Shining a light on unmet needs in HAE special patient populationsWelcome and introduction The ...
-
Mite – the “diva” in AIT trialsWelcome and introduction Fill...
-
Looking ahead to the future: Advances in HAE diagnosticsLooking ahead to the future: Advances in HAE diagnostics ...
Show more Sponsored Symposia (55)Show Less-
-
Impact of climate change on asthma exacerbations
-
Seasonal variability of exacerbations in patients with severe, uncontrolled asthma and clinical benefits of tezepelumab: Results from the PATHWAY phase 2b study
-
Dupilumab reduces severe exacerbations in patients with uncontrolled, moderate-to-severe allergic (atopic) asthma regardless of presence of perennial aeroallergen-specific IgE: LIBERTY ASTHMA QUEST
-
Effects of tezepelumab on asthma exacerbations, type 2 biomarkers, lung function and asthma control in patients with severe, uncontrolled asthma with and without nasal polyps: PATHWAY phase IIb study
-
Danger signs
-
Role Viral reactivations
-
Vaccines for older adults: benefits and limitations
-
Collective advocacy for action on CRDs
-
Delabelling adults
-
AIT in the pediatric population
-
Differential diagnosis
-
Measles infection causes immune amnesia
-
Predicting adverse reactions to biologicals
-
Viral infection and asthma
-
Epithelial cell barrier and allergic diseases
-
Lung function testing
-
An update on prevention of allergic diseases
-
Management of adverse reactions to biologics
-
Current and future perspectives
-
Inflammatory biomarkers
-
Preparing a grant: Dos and Don'ts
-
The ‘allergy tool kit’ for the transition clinic
-
The dilemma of food allergy additives
-
Unusual presentations of contact dermatitis
-
Microbiota in immune-based therapies
-
Evidence of immunotherapy on allergy prevention?
-
The clinical clues and pitfalls in contact dermatitis
-
Tezepelumab (anti-TSLP) in asthma
-
Food allergy - the beginners guide
-
Desensitization in chemotherapy and biologics
-
Novel cell based assays in allergy diagnostics
-
A patient with an acute reaction: recognize, document and treat
-
Elderly asthma
-
Launch of the Biological guidelines
-
When to evaluate children with atopic dermatitis for Type IV allergy
-
Tackling anaphylaxis
-
Tree nut allergy: path from national to global data
-
Asthma endotypes as risk factors for severe COVID-19 manifestations
-
Immune response to Corona virus infection
-
Molecular and structural considerations for aerosolization of food allergens
-
Exercise: induced asthma and rhinitis
-
Update on drug allergy
-
Covid 19 and air pollution: is there a relationship?
-
Non-steroidal anti-inflammatory drugs exacerbated disease (NERD)
-
Skin care from birth for allergy prevention: results today
-
The brain, nose, immune axis
-
Innate trained immunity: An evolutionary perspective
-
Current status on prophylaxis in HAE
-
Mental health needs and access to care among patients with food allergy
-
Using the “atopic dermatitis yardstick” in clinical practice
-
New perspectives for anaphylaxis
-
Therapies for multiple-tree nut allergies
-
Metabolic changes in the prediction of severe anaphylactic reactions
-
Asma e alergia em Angola
-
The underlying immunology of pruritus
-
AIT, Biologicals and Covid vaccination
-
Recognizing immediate reactions in contact dermatitis
-
Eosinophilic fasciitis, an unusual presentation
-
Over-the-counter allergy prevention weaning products
-
Sleep patterns and development of children with atopic dermatitis
-
Allergy to Kale
-
Assessment of adherence to treatment using mHealth
-
New and clinically relevant contact allergens
-
Implementing biomarkers in immunophenotyping of atopic dermatitis
-
Diagnosis of NSAIDs-Exacerbated respiratory disease (N-ERD)
-
Eosinophil ETosis, a cytolytic degranulation and diseases
-
Ligelizumab (anti-IgE) in chronic spontaneous urticaria
-
AAAAI Practice Parameters
-
Immune modulation in local allergic rhinitis
-
The basics of severe asthma - biomarkers
-
The role of infection in chronic spontaneous urticaria
-
Immune responses in desentitization and tolerance
-
Prevention and therapy in primary immunodeficiencies: Vaccination
-
How to classify cutaneous manifestations of drug hypersensitivity
-
Impact of climate change on the immune system
-
Early biomarkers for severe drug hypersensitivity reactions
-
Exercise-induced urticaria and anaphylaxis
-
The role of metalloproteinase 9 in the pathogenesis of atopic dermatitis in children
-
Immunological basis of food aversion
-
Pediatric Covid-19 highlights published in PAI in 2020
-
Interferon therapy in airway disease: prophylaxis is the new approach in exacerbation prevention?
-
Immunotherapy in severe asthma (AIT)
-
Oral food challenges thresholds for clinical reactions
-
Can group consultations work in allergy? Learning from rheumatology
-
Food allergy: new allergens on the block
-
Severe cutaneous allergic reactions: searching for the culprit drug
-
An update on food allergy
-
Novel pharamacological targets
-
Probiotics and prebiotics: an on-going journey
-
When to suspect allergic contact dermatitis in atopic dermatitis patients
-
Emerging evidence on the link between air pollution and COVID-19 (Pro & Con Session: Con)
-
Emerging evidence on the link between air pollution and COVID-19 (Pro & Con Session: Pro)
-
Airborne enzymes – New and re-emerging occupational hazards
-
Contact urticaria and protein contact dermatitis connecting skin and airways
-
It looks like urticaria – but is it?
-
Mechanism and prevention of epicutaneous sensitization to food allergens
-
Biomarkers and predictors of responses to biologicals in atopic dermatitis
-
Social media and Allergies: how can we support our patients?
-
Endotype-driven treatment in chronic rhinosinusitis
-
Oral food challenge versus biomarkers - are challenges still needed?
-
How to evaluate lung function? Hands-on plus lecture
-
The impact of the exposome on allergies and asthma – a global view on urbanisation, climate change and pollution
-
Developing an adolescent and young adult allergy service
-
Component Resolved Diagnosis and pollen Immunotherapy indication
-
Basophil activation tests and allergy to COVID-19 vaccines
-
Dupilumab (anti-IL4Ra) in CRSwNP
-
We are what we eat - importance of food to health, moving past simple calories
-
GINA Guidelines Update
-
Clinical manifestations of severe cutaneous adverse drug reaction
-
Asma e alergia em pandemia
-
Global impact of the COVID-19 on the environment
-
Alternative free-from foods to reach a balanced diet
-
How can we improve the quality of life of patients with severe food allergy?
-
Is There A Place For Chlorhexidine In The European Baseline Series?
-
Dupilumab in paediatric patients with eosinophilic esophagitis
-
Placebo effects in Allergen Immunotherapy: guidelines and regulatory recommendations
-
Drug reactions of the skin or Novel mechanisms of drug reactions
-
Allergy School Cork 2022 Abstract BookDownload Abstract Book
-
Molecular allergology in daily clinical practice
-
Targeted approaches for asthma
-
Moisturisers for the primary prevention of food allergy
-
Phenotypes and endotypes of occupational allergy
-
Neuroimmunology and allergy
-
Can we identify patients at risk of life-threatening allergic reaction to food?
-
Cow’s milk protein-induced allergic proctocolitis: cohort review
-
Personalized nutrition approach towards better QOL in Food Allergy
-
Weak correlation between percentage of predicted values of PEF and FEV1 parameters in children population
-
Exposome modulation and immunotherapy in infants at higher risk of respiratory allergies
-
Genetic polymorphisms of CD14 and TLR-4 and utility of probiotic therapy in adults with atopic dermatitis
-
Electronic Health in Severe Asthma
-
The clinical burden of cow’s milk allergy in childhood – a retrospective cohort study
-
Protection against lower respiratory infections in a high-risk infant cohort with a microbial-derived immunomodulator
-
Novel approaches of allergen immunotherapy
-
Impaired olfaction: diagnostics and its role in diseases
-
How do allergens sensitize?
-
Challenges on the implementation of early introduction of allergenic foods
-
Cellular tests for the diagnosing and monitoring of allergy
-
Prevention of food allergy: where are we now?
-
Early life wheeze - risk factors for asthma in school age
-
Gaps in the management of food-induced anaphylaxis reactions at school
-
Impact of food allergy on household expenditures among Manitoba families
-
Does pediatric asthma primarily depend on submicrone aerosol pollutants?
-
Does human milk and its composition matter for development and prevention of allergies?
-
Big changes in asthma treatment : GINA 2019
-
Update of the WAO anaphylaxis guidance
-
Efficacy of venom immunotherapy: How long should patients be treated?
-
FAAM-EUROBAT Opening ceremony
-
Should we use partial allergen sequence information for food allergy risk assessment?
-
Development of a childhood asthma prediction model using machine learning approaches
-
Risk assessment and active management of food allergy
-
Using BAT for differentiation between sensitization and allergy to alpha-gal
-
Ligelizumab in adolescent patients with chronic spontaneous urticaria: results from a dedicated phase 2b study
-
ÖGAI: Covid as best practice model to combine immunology and allergy
-
Environmental epigenomics of allergy
-
Nasal allergen challenge
-
A cohort study into intravenous drug provocation tests in perioperative allergy
-
The role of the extended provocation test: Diagnosing non-immediate beta-lactam hypersensitivity in paediatrics
-
Venom immunotherapy in predominant Api m 10 sensitization: Does it work?
-
Allergenicity and IgE recognition of new Dau c 1 allergens from carrot
-
Autoimmunity in atopic diseases
-
Multiple myeloma exosomes suppress natural killer cells: Modification by omega-3 fatty acids
-
Paediatric multisystem allergy: a new diagnostic and severity score
-
EAACI Biologicals Guidelines – Recommendations for Severe Asthma
-
Precision Medicine and AIT
-
Disease burden and treatment of moderate-to-severe atopic dermatitis (AD) in children aged <12 years: results from 732 patients in the PEDISTAD observational study
-
Focus on Patient. Personalised therapy for severe asthma
-
Implementation of telehealth in asthma management: trials and tribulations
-
Are drug provocation tests required before decision to desensitize?
-
Pathophysiology and diagnostic innovation in ocular allergy
-
Late onset T2 asthma – a case study
-
Trichinella spiralis infection associated with chronic spontaneous urticaria - case series
-
Skin test, drug provocation and laboratory tests: which ones and when?
-
Prescribing immunotherapy to pollens in children: influence of geographical and sociological diversity
-
Food industry perspective
-
Occupational respiratory allergy in food processing industries
-
Elevated tryptase – Now what?
-
When hives are not chronic urticaria
-
Biological severe asthma treatment in Poland - pros and cons of drug programme
-
Psychological support to peanut allergic children and their families
-
Impacting quality of life with PALFORZIA
-
Route of exposure determines the immune response to food allergens
-
AI models
-
Difficult to control asthma in children
-
Pediatric Asthma in Real Life (PeARL): addressing controversies in pediatric asthma
-
COVID-19 Vaccination: Separating facts from fiction for your patients
-
BAT in clinical practice. Is it possible?
-
Flexible and rigid dendrimer-based nanostructures for cell effector studies in the context of amoxicillin allergy
-
Hypersensitivity to antiepileptic drugs
-
Understanding parent preferences for paediatric allergy services
-
Precision medicine and biomarkers of atopic dermatitis
-
Role of antigen-presenting cells in tolerance and allergy
-
Why is a transition clinic needed for adolescents and young adults (AYA) with allergy and asthma?
-
Worldwide survey shows that atopic dermatitis is associated with a high disease burden in adolescents
-